hashimoto's and semaglutide The Thyroid Twist: How GLP-1 Agonists Are Influencing Autoimmune Thyroid Care Microdosing GLP-1 for Hashimoto's: Evidence,
Description
doi: 10.1002/PHAR.4607 45 LiuZBianNWuSFanYLiHYuJet al
To our knowledge, no retrospective studies have been conducted to assess the effectiveness of semaglutide at the doses used to treat obesity (ie, 1.7 and 2.4 mg). Researchers conducted a cohort study at a referral center for weight management and included 175 patients (mean age, 49.3 years
doi: 10.3390/ijms24032464
Still, if you have symptomatic palpitations, an unexplained rapid pulse, or a known arrhythmia, clinicians will weigh that effect when choosing therapy and monitoring
In that case, nutrient intake becomes even more important
